Deepa Subramaniam, M.D., M.S. is a Scientific Oncology Executive currently serving as the Vice President and Head of Early-Stage Clinical Development at Revolution Medicines. With over two decades of experience in drug development from preclinical to Phase 3, Deepa has a proven track record in fostering cross-functional collaboration and optimizing oncology doses. Previously, Deepa was an Executive Medical Director at AstraZeneca and held positions such as Associate Professor and Founding Director of the Georgetown-Lombardi Brain Tumor Center at MedStar Georgetown University Hospital. Deepa's educational background includes a Bachelor's in Medicine from Government Kilpauk Medical College and multiple specialized fellowships from Georgetown University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices